Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes

European Journal of Human Genetics

Volumn 23, Issue 12, 2015, Pages 1593-1600

  Howard, Heidi Carmen ^a   Knoppers, Bartha Maria ^b   Cornel, Martina C ^c   Wright Clayton, Ellen ^d   Sénécal, Karine ^b   Borry, Pascal ^e  

^a UPPSALA UNIVERSITY   (Sweden)

^b MCGILL UNIVERSITY   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE SEQUENCE; GENETIC VARIABILITY; GENOME; HIGH RISK POPULATION; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; NEWBORN PERIOD; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SCREENING TEST; WHOLE GENOME SEQUENCING; DNA SEQUENCE; GENETIC SCREENING; GENOME-WIDE ASSOCIATION STUDY; HEALTH CARE PLANNING; NEWBORN; PROCEDURES; STANDARDS; TRENDS;

GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HEALTH PLANNING GUIDELINES; HUMANS; INFANT, NEWBORN; SEQUENCE ANALYSIS, DNA;

EID: 84948712119     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.289     Document Type: Article

References (51)

1. Wright C. Next Steps in the Sequence: the Implications of Whole Genome Sequencing for Health in the UK. Cambridge, UK. PHG Foundation, 2011
2. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. The Lancet 2010; 375: 1525-1535
3. Nepomnyashchaya YN, Artemov AV, Roumiantsev SA, Roumyantsev AG, Zhavoronkov A. Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations. Clin Chem Lab Med 2013; 51: 1141-1154
4. Hayden EC. Sequencing set to alter clinical landscape. Nature 2012; 482: 288
5. Johansen Taber KA, Dickinson BD, Wilson M. The promise and challenges of nextgeneration genome sequencing for clinical care. JAMA Intern Med 2013; 174: 275-280
6. Goldenberg AJ, Sharp RR. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 2012; 307: 461-462
7. Carmichael M. A spot of trouble. Nature 2011; 475: 156-158
8. Loeber JG, Burgard P, Cornel MC, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J Inherit Metab Dis 2012; 35: 603-611
9. Burgard P, Rupp K, Lindner M, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis 2012; 35: 613-625
10. Cornel MC, Rigter T, Weinreich SS, et al. A framework to start the debate on neonatal screening policies in the EU. an Expert Opinion Document. Eur J Hum Genet 2014; 22: 12-17
11. Wilson J, Jungner G. Principles and Practice of Screening for Disease. Geneva: WHO, 1968
12. Moyer VA, Calonge N, Teutsch SM, Botkin JR. Expanding newborn screening: process, polity, and priorities. Hastings Cent Rep 2008; 38: 32-39
13. Avard D, Vallance H, Potter B, Greenberg C. Newborn screening by tandem mass spectrometry: Ethical and social issues. Canadian Journal of Public Health/Revue Canadienne de Santé Publique 2007; 98: 284-286
14. Wilson K, Kennedy SJ, Potter B, Geraghty MT, Chakraborty P. Developing a national newborn screening strategy for Canada. Health Law Rev 2010; 18: 31-39
15. US Department of Health and Human Services. Discretionary Advisory Committee on Heritable Disorders in Newborns and Children. Recommended Uniform Screening Panel. 2013 http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendedpanel/. Accessed 5 January 2015
16. The President's Council on Bioethics: The Changing Moral Focus of Newborn Screening. An Ethical Analysis by the President's Council on Bioethics. Washington DC. President's Council on Bioethics, 2008
17. Baily MA, Murray TH. Ethics, evidence, and cost in newborn screening. Hastings Center Report 2008; 38: 23-31
18. Botkin JR. Research for newborn screening: developing a national framework. Pediatrics 2005; 116: 862-871
19. Andermann A, Blancquaert I, Beauchamp S, Dery V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008; 86: 317-319
20. Burgard P, Cornel M, Di Filippo F, et al. Report on the practices of newborn screening for rare disorders implemented in Member States of the European Union, Candidate, Potential Candidate and EFTA Countries 2014, http://www.iss.it/binary/cnmr/cont/Report-NBS-Current-Practices-20120108-FINAL.pdf. Accessed 5 January 2015
21. Castellani C, Massie J. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary? Eur Resp J 2014; 43: 20-23
22. Department of Health: Our Inheritance, Our Future. Realising the Potential of Genetics in the NHS. London: Department of Health, NHS, 2003
23. Collins F. The Language of Life: DNA and the Revolution in Personalized Medicine. New York: Harper Collins, 2010
24. Young S. Does Illumina Have the First $1, 000 Genome? MIT Technol Rev 2014, http://www.technologyreview.com/news/523601/does-illumina-have-The-first-1000-genome/. Accessed 5 January 2015
25. Frank M, Prenzler A, Eils R, Graf von der Schulenburg JM. Genome sequencing: a systematic review of health economic evidence. Health Econ Rev 2013; 3: 29
26. Mardis ER. The $1, 000 genome, the $100, 000 analysis? Genome Med 2010; 2: 84
27. Kroos M, Hoogeveen-Westerveld M, Van der Ploeg A, Reuser AJ. The genotypephenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet 2012; 160C: 59-68
28. Capps B, Chadwick R, Chalmers DRC, et al. Imagined futures: capturing the benefits of genome sequencing for society 2013, http://hugo-international.org/img/Capturing-the-benefits-of-genome-sequencing-for-society.pdf. Accessed 5 January 2015
29. Knoppers BM, Thorogood A, Chadwick R. The Human Genome Organisation: towards next-generation ethics. Genome Med 2013; 5: 38
30. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science 2013; 339: 321-324
31. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565-574
32. van El CG, Cornel MC, Borry P, et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet 2013; 21(Suppl 1): S1-S5
33. Kaiser J NIH Studies explore promise of sequencing babies' genomes 2013, http://news.sciencemag.org/biology/2013/09/nih-studies-explore-promisesequencing-babies%E2%80%99-genomes Accessed 5 January 2015
34. NIH program explores the use of genomic sequencing in newborn healthcare, 2013, http://www.nih.gov/news/health/sep2013/nhgri-04.htm. Accessed 22 August 2014
35. Wade CH, Tarini BA, Wilfond BS. Growing up in the genomic era: implications of wholegenome sequencing for children, families, and pediatric practice. Annu Rev Genomics Hum Genet 2013; 14: 535-555
36. Knoppers BM, Senecal K, Borry P, Avard D. Whole-genome sequencing in newborn screening programs. Sci Transl Med 2014; 6: 229 cm2
37. van El CG, Cornel MC, Borry P, et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet 2013; 21(Suppl 1): S1-S5
38. Bloss CS, Schork NJ, Topol EJ. Effect of direct-To-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524-534
39. Evans JP, Berg JS, Olshan AF, Magnuson T, Rimer BK. We screen newborns, don't we?: realizing the promise of public health genomics. Genet Med 2013; 15: 332-334
40. International Society for Neonatal Screening. ISNS General guidelines for neonatal screening 2013, http://www.isns-neoscreening.org/nl/pages/24-isns-general-guidelines-for-neonatal-screening. Accessed 5 January 2015
41. Caulfield T, Evans J, McGuire A, et al. Reflections on the cost of low-cost whole genome sequencing: framing the health policy debate. PLoS Biol 2013; 11: e1001699
42. Bombard Y, Miller FA, Hayeems RZ, Avard D, Knoppers BM. Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet 2010; 18: 751-760
43. Clayton EW, McCullough LB, Biesecker LG, et al. Addressing the ethical challenges in genetic testing and sequencing of children. Am J Bioeth 2014; 14: 3-9
44. Detmar S, Hosli E, Dijkstra N, et al. Information and informed consent for neonatal screening: opinions and preferences of parents. Birth 2007; 34: 238-244
45. Hargreaves K, Stewart R, Oliver S. Newborn screening information supports public health more than informed choice. Health Educ J 2005; 64: 110-119
46. Jepson RG, Forbes CA, Sowden AJ, Lewis RA. Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expect 2001; 4: 116-126
47. American Academy of Pediatrics Newborn Screening Task Force: Serving the family from birth to the medical home: newborn screening: a blueprint for the future Pediatrics 2000 106 389-427
48. Therrell BL Jr, Hannon WH. Newborn dried blood spot screening: residual specimen storage issues. Pediatrics 2012; 129: 365-366
49. Sharp RR. Downsizing genomic medicine: approaching the ethical complexity of wholegenome sequencing by starting small. Genet Med 2011; 13: 191-194
50. Goldenberg AJ, Dodson DS, Davis MM, Tarini BA. Parents'interest in whole-genome sequencing of newborns. Genet Med 2014; 16: 78-84
51. European Society of Human Genetics: Statement of the ESHG on direct-To-consumer genetic testing for health-related purposes Eur J Hum Genet 2010 18 1271-1273